Clinical trial
Atomoxetine Treatment for ADHD and Marijuana Dependence
NCT00360269 is registered in ClinicalTrials.gov with Medical University of South Carolina as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Atomoxetine Treatment for ADHD and Marijuana Dependence
- Lead sponsor
- Medical University of South Carolina
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- November 30, 2005
- Completion date
- June 30, 2008
- Enrollment
- 38 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.